Trends in Naloxone Dispensing From Retail Pharmacies in the US.
作者信息
Rikard S Michaela, Strahan Andrea E, Schieber Lyna Z, Guy Gery P
机构信息
Division of Overdose Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
出版信息
JAMA. 2024 Jul 9;332(2):165-167. doi: 10.1001/jama.2024.8323.
Abstract
摘要
相似文献
1
Trends in Naloxone Dispensing From Retail Pharmacies in the US.美国零售药店纳洛酮配药趋势。
JAMA. 2024 Jul 9;332(2):165-167. doi: 10.1001/jama.2024.8323.
2
State laws that authorize pharmacists to prescribe naloxone are associated with increased naloxone dispensing in retail pharmacies.州法律授权药剂师开纳洛酮处方与零售药店纳洛酮配药的增加有关。
Drug Alcohol Depend. 2021 Oct 1;227:109012. doi: 10.1016/j.drugalcdep.2021.109012. Epub 2021 Aug 28.
3
Increase in Naloxone Prescriptions Dispensed in US Retail Pharmacies Since 2013.自2013年以来美国零售药店纳洛酮处方配药量的增加。
Am J Public Health. 2016 Apr;106(4):689-90. doi: 10.2105/AJPH.2016.303062. Epub 2016 Feb 18.
4
Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018.生命体征：2012-2018 年美国基于药房的纳洛酮配药情况。
MMWR Morb Mortal Wkly Rep. 2019 Aug 9;68(31):679-686. doi: 10.15585/mmwr.mm6831e1.
5
Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States.纳洛酮共开处方法律与美国纳洛酮处方配药的关联。
JAMA Netw Open. 2019 Jun 5;2(6):e196215. doi: 10.1001/jamanetworkopen.2019.6215.
6
Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.根据宾夕法尼亚州的常规医嘱，培训药剂师以增加社区药房内纳洛酮的配药量。
Am J Health Syst Pharm. 2021 Feb 8;78(4):327-335. doi: 10.1093/ajhp/zxaa387.
7
The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United States.纳洛酮索赔与独立药店和连锁药店比例之间的关联：美国纳洛酮索赔的纵向分析。
J Am Pharm Assoc (2003). 2024 Jul-Aug;64(4):102093. doi: 10.1016/j.japh.2024.102093. Epub 2024 Apr 10.
8
Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.态度与可得性：阿拉巴马州农村和城市地区连锁和独立药店纳洛酮配给情况比较。
Int J Drug Policy. 2019 Dec;74:229-235. doi: 10.1016/j.drugpo.2019.09.021. Epub 2019 Nov 5.
9
Evaluation of naloxone access, pricing, and barriers to dispensing in Tennessee retail community pharmacies.田纳西州零售社区药店纳洛酮获取、定价和配药障碍评估。
J Am Pharm Assoc (2003). 2020 Sep-Oct;60(5):694-701.e1. doi: 10.1016/j.japh.2020.01.030. Epub 2020 Mar 4.
10
Distribution of naloxone for overdose prevention to chronic pain patients.为预防药物过量向慢性疼痛患者分发纳洛酮。
Prev Med. 2015 Nov;80:41-3. doi: 10.1016/j.ypmed.2015.05.016. Epub 2015 May 27.
引用本文的文献
1
Over-the-Counter Retail Naloxone Sales.非处方零售纳洛酮销售
JAMA Intern Med. 2025 Sep 15. doi: 10.1001/jamainternmed.2025.4590.
2
Enhancing Naloxone Distribution for Opioid Users in the USA: A Cost-Utility Analysis of Academic Detailing to Clinicians.在美国为阿片类药物使用者增加纳洛酮的分发：对临床医生进行学术推广的成本效用分析。
Appl Health Econ Health Policy. 2025 Jul 20. doi: 10.1007/s40258-025-00991-8.
3
Awareness of and Beliefs About Naloxone Among Adults.成年人对纳洛酮的认知与看法
JAMA Health Forum. 2025 Jun 7;6(6):e251867. doi: 10.1001/jamahealthforum.2025.1867.
4
Naloxone Knowledge, Carrying, Purchase, and Use.纳洛酮知识、携带、购买及使用
JAMA Netw Open. 2025 Mar 3;8(3):e2462698. doi: 10.1001/jamanetworkopen.2024.62698.
Zotero 插件